Relationships between the results of lipid profiling, and the levels of matrix metalloproteinases in blood serum in apparently healthy women of different ages

Cover Page

Cite item

Full Text

Abstract

The issues of active longevity are extremely important both for humanity as a whole, and for each individual. There is no unified theory of aging today. Gerontologists agree that aging is caused by many factors that act simultaneously or sequentially. At the same time, most modern theories are based on the study of individual processes occurring during the aging of the body. The aging process alters lipid metabolism by regulating several important pathways involved in lipid transport. In addition, the retention of cholesterol-rich lipoprotein apeS in the artery walls causes several modifications and important biological consequences, including those induced by matrix metalloproteinases (MMPs) which show increased expression with age. The aim of our study was to analyze the values of serum lipid profiling and MMP levels in women of different age, and to assess their interrelations. The study included 157 women, distributed by age (the WHO criteria). The subjects underwent initial medical examination at the clinical bases of the Pacific State Medical University, where the levels of total cholesterol, high-density lipoproteins, low-density lipoproteins, triglycerides, apoliproteins A1, B and MMP values in blood serum were determined. Statistical evaluation of the obtained results was carried out using IBM SPSS Statistics 26 package using nonparametric statistics methods. Results: In conditionally healthy women, depending on age, the total cholesterol levels were high at the age of 45-59 years. In the aged group, this index was significantly reduced. HDL was significantly reduced in the aged group, whereas low-density lipoproteins (LDL) were, on the contrary, increased. The ApoB level was reduced in women under 45 years of age, being increased in the age group of 60-74 years. The ApoB/ApoA1 index was lower in the younger age group compared to women aged > 45 years. In conditionally healthy women, MMP-1 values were higher in the middle-aged group. MMP-2 was higher in the middle-aged group, but its highest levels were recorded among the women over 75 years old. MMP-3 did not show any dependence on age. In women over 75 years old, MMP-7 was lower than the values in other age groups. MMP-9 was higher in the group of women aged 45-59 years. According to results of the correlation analysis, conditionally healthy women showed a direct medium-strength relation between the level of ApoB and MMP-2, which correlated with advanced age.

About the authors

Natalya S. Chepurnova

Pacific State Medical University

Author for correspondence.
Email: dr.cns@yandex.ru
ORCID iD: 0000-0001-6642-1332
SPIN-code: 6726-8523

PhD (Medicine), Associate Professor, Department of Normal and Pathological Physiology

Russian Federation, Vladivostok

Vladimir N. Jushhuk

Pacific State Medical University

Email: Dr.cns@yandex.ru
SPIN-code: 7096-1850

Assistant Professor, Department of Public Health

Russian Federation, Vladivostok

Elena V. Markelova

Pacific State Medical University

Email: markev2010@mail.ru
ORCID iD: 0000-0001-5846-851X
SPIN-code: 3661-5026

PhD, MD (Medicine), Professor, Head, Department of Normal and Pathological Physiology

Russian Federation, Vladivostok

Margarita A. Visjagina

Pacific State Medical University

Email: margovisyagina@gmail.com

Assistant Professor, Department of Normal and Pathological Physiology

Russian Federation, Vladivostok

References

  1. Грачев Н.И., Красников В.Е., Турмова Е.П., Маркелова Е.В., Рублев В.Ю., Назаренко С.А. Анализ показателей матриксной металлопротеиназы-9, тканевого ингибитора матриксных металлопротеиназ 1-го типа и их комплекса у пациентов с острым инфарктом миокарда, подвергшихся чрескожным коронарным вмешательствам // Тихоокеанский медицинский журнал, 2018. № 4. С. 45-48. [Grachev N.I., Krasnikov V.E., Turmova E.P., Markelova E.V., Rublev V.Yu, Nazarenko S.A. Аnalysis of matrix metalloproteinase-9, tape inhibitor of matrix metalloproteinase type 1 and their complex in patients with acute miocard infarction who have exposed high coronary interventions. Tikhookeanskiy meditsinskiy zhurnal = Pacific Medical Journal, 2018, no. 4, pp. 45-48. (In Russ.)]
  2. Копычева И.И. Причины старения организма // Наука-2020, 2018. № 2-1. С. 21-25. [Kopycheva I.I. Causes of aging of the body. Nauka-2020 = Science-2020, 2018, no. 2-1, pp. 21–25. (In Russ.)]
  3. Михалева И.А., Ноздрачева Е.В. Влияние биохимических показателей липидного обмена на функциональное состояние сердечно-сосудистой системы человека // Ученые записки Брянского государственного университета, 2020. № 4. С. 74-78. [Mihaleva I.A., Nozdracheva E.V. The influence of biochemical indicators of lipid metabolism on the functional state of the human cardiovascular system. Uchenye zapiski Bryanskogo gosudarstvennogo universiteta = Scientific Notes of Bryansk State University, 2020, no. 4, pp. 74-78. (In Russ.)]
  4. Chung K.W., Lee E.K., Lee M.K., Oh G.T., Yu B.P., Chung H.Y. Impairment of PPARalpha and the fatty acid oxidation pathway aggravates renal fibrosis during aging. J. Am. Soc. Nephrol., 2018, Vol. 29, no. 4, pp. 1223-1237.
  5. Garvin P., Nilsson L., Carstensen J., Jonasson L., Jonasson L., Kristenson M. Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population. PLoS ONE, 2008, Vol. 3, no. 3, e1774. doi: 10.1371/journal.pone.0001774.
  6. Mancuso P., Bouchard B. The impact of aging on adipose function and adipokine synthesis. Front. Endocrinol., 2019, Vol. 10, 137. doi: 10.3389/fendo.2019.00137.
  7. Medley T.L., Kingwell B.A., Gatzka C.D., Pillay P., Cole T.J. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ. Res., 2003, Vol. 92, no. 11, pp. 1254-1261.
  8. Pietrzak J., Mirowski M., Jeleń A., Świechowski R., Wodziński D., Niebudek K., Balcerczak E. Decreased MMP1 gene expression in acute myeloid leukaemia. Mol. Biol. Rep., 2019, Vol. 46, no. 2, pp. 2293-2298.
  9. Simões G., Pereira T., Caseiro A. Matrix metaloproteinases in vascular pathology. Microvasc. Res., 2022, Vol. 143, 104398. doi: 10.1016/j.mvr.2022.104398.
  10. Wang X. Khalil R.A. Matrix metalloproteinases, vascular remodeling, and vascular disease. Adv. Pharmacol., 2018, Vol. 81, pp. 241-330.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2026 Chepurnova N.S., Jushhuk V.N., Markelova E.V., Visjagina M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).